LAUSR

The role of early palliative care involvement for patients with cancer is being increasingly recognized for patients with incurable cancer as more studies demonstrate that it is feasible, cost-effective and efficacious. Patients benefit from improved symptom control, better supported decision making and improved quality of life. It has been shown to be effective alongside disease-modifying treatment, and evidence supports the use of multidisciplinary care in a co-management role. It is also a cost-effective way to reduce unnecessary and overly-aggressive treatment at the end of life. Efforts are needed to alleviate persistent misconceptions and support program development in areas where access is limited.